Ardent Health, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-14.
0001628280-25-052362
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-06.
0001628280-26-031299
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 7 previous paragraphs and 13 current paragraphs.
5 unchanged; 2 reworded; 5 added; 0 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors that we believe are material to our business, results of operations and
Added paragraphs (5)
Current report
In November 2025, our Board of Directors authorized a stock repurchase program pursuant to which we may repurchase an
Current report
aggregate of up to $50.0 million of our common stock through open market purchases, privately negotiated transactions,
Current report
block trades or other transactions in accordance with applicable securities laws, subject to market conditions and other
Current report
factors. The program has no expiration date. At March 31, 2026, there was approximately $46.8 million of stock repurchase
Current report
authorization remaining under the stock repurchase program. We did not repurchase any shares under the stock repurchase
Reworded paragraphs (2)
Previous wording
During the three months ended September 30, 2025, we made the following purchases of our equity securities that are
Current wording
During the three months ended March 31, 2026, we made the following purchases of our equity securities that are registered
Previous wording
registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Current wording
pursuant to Section 12(b) of the Securities Exchange Act of 1934 (dollars in millions, except per share amounts):
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
program during the three months ended March 31, 2026.